We observed that deletion of p38α‐MAPK attenuated Aβ load and neuronal deficits of AD mice; however, the pathogenic mechanism of p38α‐MAPK is evolving during the disease progresses, which potentially involves peripheral interleukin (IL)‐17a‐expressing T lymphocytes. Here, IL17A is linked to Alzheimer disease.